1 |
Duong-Quy S, Huynh-Truong-Anh D, Tran-Xuan Q, Nguyen-Quang T, Nguyen-Thi-Kim T, Nguyen-Chi T, Tran-Ngoc-Anh T, Nguyen-Van-Hoai N, Do-Thi-Thu M, Tang-Thi-Thao T, Bui-Diem K, Hoang-Anh T, Nguyen-Ngoc-Phuong T, Nguyen-Nhu V. Bradycardia unresponded to atropin testing was successfully treated with therapeutic plasma exchange in a patient with severe COVID-19 complicated by Guillain-Barré syndrome: A case report. Front Cardiovasc Med 2022;9:1035896. [PMID: 36741850 DOI: 10.3389/fcvm.2022.1035896] [Reference Citation Analysis]
|
2 |
da Silva Júnior RT, Santos Apolonio J, Cuzzuol BR, da Costa BT, Silva CS, Araújo GRL, Silva Luz M, Marques HS, Santos LKS, Pinheiro SLR, Lima de Souza Gonçalves V, Calmon MS, Freire de Melo F. COVID-19 neuropsychiatric repercussions: Current evidence on the subject. World J Methodol 2022; 12(5): 365-380 [DOI: 10.5662/wjm.v12.i5.365] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
3 |
Scorza FA, Finsterer J. Apparent onset of COVID-19 after onset of SARS-CoV-2 associated Guillain-Barre syndrome. Travel Med Infect Dis 2021;44:102201. [PMID: 34774758 DOI: 10.1016/j.tmaid.2021.102201] [Reference Citation Analysis]
|